Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on January 30, 2008
J Am Soc Nephrol 19: 656-659, 2008
© 2008 American Society of Nephrology
doi: 10.1681/ASN.2007111204
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2007111204v1
19/4/656    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Textor, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Textor, S. C.

Clinical Commentary

Atherosclerotic Renal Artery Stenosis: Overtreated but Underrated?

Stephen C. Textor

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota

Correspondence: Dr. Stephen C. Textor, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN 55905. Phone: 507-284-4083; Fax: 507-284-1161; E-mail: textor.stephen{at}mayo.edu

Despite evidence of only moderate clinical benefit, application of renal endovascular stent procedures has increased at least four-fold in the past decade. Medicare is reviewing national coverage regarding reimbursement, questioning whether outcome data warrant many of these procedures. Several prospective, randomized trials are now in progress to compare outcomes with optimized medical therapy with and without stenting. Current imaging methods establish primarily the presence and severity of vascular occlusive disease. Optimal treatment for individual patients remains in flux and is reviewed here. Most important, nephrologists await development of tools to predict reliably when renal parenchymal injury is beyond recovery and/or when revascularization can produce meaningful salvage of kidney function.




This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
L. Tolkin, M. Bursztyn, I. Z. Ben-Dov, N. Simanovsky, and N. Hiller
Incidental renal artery calcifications: a study of 350 consecutive abdominal computed tomography scans
Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2170 - 2175.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
L. Bax, A.-J. J. Woittiez, H. J. Kouwenberg, W. P.T.M. Mali, E. Buskens, F. J.A. Beek, B. Braam, F. T.M. Huysmans, L. J. Schultze Kool, M. J.C.M. Rutten, et al.
Stent Placement in Patients With Atherosclerotic Renal Artery Stenosis and Impaired Renal Function: A Randomized Trial
Ann Intern Med, June 16, 2009; 150(12): 840 - 848.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll Cardiol IntvHome page
S. C. Textor, L. Lerman, and M. McKusick
The Uncertain Value of Renal Artery Interventions: Where Are We Now?
J. Am. Coll. Cardiol. Intv., March 1, 2009; 2(3): 175 - 182.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673